Skip to main content

Ginkgo Bioworks Holdings, Inc.

For the period ended Jun 11, 2026. Filed Apr 29, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 11, 2026 · Filed Apr 29, 2026

DNA$11.29+13.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

2026 Performance Equity Program

On February 26, 2026, the Compensation Committee approved a performance-based equity incentive program (the “2026 Performance Equity Program”), substantially similar to the 2025 Performance Equity Program, under which PSUs and RSUs that vest in quarterly installments over one year were granted to substantially all employees. Mr. Coen was awarded PSUs and no RSUs, with the certification of the PSUs expected to take place in early 2027.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.